National survey shows improvement in pre-authorization delays; healthcare providers call for increased transparency of AI
PR Newswire
16m ago
Ai Focus
A survey on national medical service providers conducted in 2026, released by Cohere Health, shows that the number of patients who gave up treatment or turned to emergency services due to delays in prior authorization has significantly decreased year-on-year. However, medical service providers still hope that AI will reduce administrative burdens and speed up approval processes while maintaining transparency and consistency, as well as preserving human supervision and clinical judgment.
Helpful
No.Help

The second annual survey found that delays in authorization have decreased; at the same time, healthcare providers are calling for more transparent AI to reduce administrative burdens and preserve clinical judgment.

Boston, November 16, 2026 /PRNewswire/ — The clinical intelligence and operations platform for healthcare insurance plans, Cohere Health, today released the results of its “2026 National Pre-Authorization Healthcare Providers Survey.” The survey shows that due to delays in pre-authorization, there has been a significant decrease in patients abandoning treatment or turning to emergency care compared to last year. The survey also found that nearly all healthcare providers – including 96% of clinicians and 94% of office administrators – still trust the AI process in pre-authorization, but this trust is becoming more conditional as healthcare providers call for increased transparency, consistency, and manual oversight to reduce administrative burdens and to support timely healthcare services involving informed participation by clinicians.

Pre-authorization is a process in medical insurance plans that involves review before certain treatments are carried out. Its original intention was to support appropriate and evidence-based medical services, but it has now become one of the most administratively burdensome procedures within the healthcare system, often causing friction between insurance plans and healthcare providers. Despite ongoing efforts in the industry to modernize this process, surveys show that healthcare providers are still dealing with manual and opaque procedures that prevent them from focusing on patients and also affect their constantly changing relationships with AI.

"It is a meaningful progress that fewer patients are giving up treatment or ending up in the emergency room due to delays in pre-authorization," said Dr. Brian Covino, Chief Medical Officer of Cohere Health. "However, healthcare providers are still actively speaking up for patients who face medical barriers. They hope that AI can reduce manual work and speed up medical services, while still allowing clinical judgment and human supervision to remain the primary focus. We fully agree with this view: AI should never be used to deny medical care, but rather to help simplify administrative tasks so that healthcare providers can focus on making the most important decisions for patients."

The survey results show measurable improvements in the accessibility of medical services and outcomes related to delays. Among the 200 clinical doctors and office administrators surveyed, reports of patients abandoning recommended treatments due to authorization delays were approximately halved compared to the previous year: this proportion among doctors dropped from 55% to 28%. At the same time, there was also a reduction in reports of avoidable emergency visits or hospitalizations related to delays. Meanwhile, providers of medical services have become more cautious regarding AI; they believe that the most valuable AI is a AI that can handle routine administrative tasks and help to expedite the authorization process.

Although reports of health-related adverse consequences due to delays have decreased, pre-authorization still imposes a heavy administrative burden on healthcare providers who deal with this process every day: unclear documentation requirements and inconsistent procedures across different insurance plans lead to avoidable rejections when healthcare providers are unsure of what is needed and when it is required. Simply increasing automation will not alleviate this friction, nor will it win the trust of healthcare providers if the process itself remains unchanged.

This creates an opportunity to improve the experience for medical insurance plans: by simplifying work processes, clarifying requirements, and applying AI in a way that healthcare providers consider transparent, accountable, and trustworthy. Healthcare providers' expectations for AI go beyond pre-authorization; they hope for clearer rules, more comprehensive guidance, and they wish that AI can reduce administrative burdens while still preserving professional judgment. For medical insurance plans, pre-authorization is a natural starting point for building trust with healthcare providers and for establishing higher standards of collaboration throughout the organization; it also serves as a testing ground.

This survey was conducted in collaboration by Cohere Health and Wakefield Research, involving 200 clinical doctors and office administrators from hospitals and medical systems across the United States. For the full results, please refer to the latest white paper " Better AI , Not Less AI ", which is now available at www.coherehealth.com / thought-leadership / provider-ai-prior-authorization-survey.

About Cohere Health

Cohere Health indicates that its clinical intelligence and operational platform, along with solutions driven by the proxy AI, connect the strategic goals of medical insurance plans with the needs of healthcare providers, thereby optimizing the speed, cost, and quality of medical services. Through enterprise-level approaches, the company has simplified the decision-making processes for payers and service providers throughout the entire healthcare continuum – including policies, pre-authorization, payment accuracy, etc. – thus improving collaboration and reducing burdens, resulting in a return on investment of up to 9 times and a satisfaction rate of 94% among healthcare providers. Cohere Health has been selected for Time Magazine’s list of the top global health technology companies of 2026, the 2026 Inc 5000 list, and has been recognized by numerous industry analysts.

Media Contact

Brynn Spicher

anthonyBarnum Public Relations
[ email protected ]

Message source: Cohere Health

Tip
$0
Like
0
Save
0
Views 21
CoinMeta reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
AMD Completes the Acquisition of World Labs
AMD announces the completion of its acquisition of World Labs, stating that this move will bring a world-class model team to its AI technology stack. Dr. Fei from Fei Li will assume the role of Executive Vice President and Chief Scientist at AMD, reporting directly to CEO Lisa Su.
GlobeNewswire
·2026-11-16 22:28:31
9
NVIDIA Lacks a Chief Compliance Officer; Board of Directors Faces Supervision Challenges
NVIDIA's sudden personnel changes have drawn external attention to its compliance with export controls and board supervision. U.S. Treasury Secretary Janet Yellen has questioned whether potential violations involve senior management, and the article states that the board needs to prove the effectiveness of its compliance and disclosure mechanisms.
Fortune
·2026-11-16 22:28:29
9
US Department of Commerce Tightens Restrictions on Vulnerabilities in Third Countries, Limiting China's Access to NVIDIA's Computing Power
On Monday, the U.S. Department of Commerce took action to close a loophole that allowed Chinese companies to rent advanced computing power from NVIDIA through data centers in third countries, thereby circumventing export controls on sensitive technologies. The department stated that this temporary final rule was drafted under the leadership of the U.S. Treasury Department and the National Security Council.
CNBC
·2026-11-16 22:28:27
8
Samsung, SK Hynix, and Micron Colluded to Create a Memory Shortage? U.S. Judge Refuses to Dismiss Antitrust Lawsuit
U.S. federal judge dismisses motions by Samsung, SK, SK Hynix, and Micron to dismiss a class-action lawsuit over price manipulation, finding the conspiracy allegations raised by the plaintiffs reasonable; case will now enter the evidence collection phase. The plaintiffs claim that the three companies coordinated in reducing production, shifting to HBM, withdrawing from DDR4, and in customer survey responses, among other aspects, and the court believes that some of these circumstances are sufficient to support a reasonable inference of collusion.
Wallstreetcn
·2026-11-16 22:18:33
9
Strive Invests $17.5 million to buy another 251 bitcoins, raising total holdings to 43,404
Strive, who also serves as CEO Matthew Cole, stated on Monday that the company purchased 251 bitcoins at an average price of $69,853 each last week, costing $17.5 million, which increased the total holdings to 43,404 bitcoins. According to the 8-K filing submitted on Monday, these purchases occurred between November 7th and November 13th; during the same period, the company raised $10.02 million through a SATS market price issuance plan, and cash and cash equivalents decreased to $465.3 million.
Bitcoin Magazine
·2026-11-16 22:18:29
16
View More